Mereo BioPharma Group Plc (MREO)
0.2344
0.00 (0.00%)
USD |
NASDAQ |
May 19, 16:00
0.2344
0.00 (0.00%)
After-Hours: 17:08
Mereo BioPharma Group Shareholders Equity (Quarterly) : 34.05M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 29.50M |
| Bicycle Therapeutics Plc | 554.32M |
| Autolus Therapeutics Plc | 108.83M |
| DBV Technologies SA | 207.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.61M |
| Total Liabilities (Quarterly) | 6.56M |
| Current Ratio | 6.481 |
| Net Debt Paydown Yield | 2.45% |